Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 16714-248

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 16714-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fosaprepitantinjcont (Fosaprepitantinjcont)

Label for Fosaprepitant for Injection 150 mg per vial, a lyophilized powder for intravenous solution. It is a single-dose vial labeled for refrigerated storage at 2°C to 8°C (36°F to 46°F). The label includes usage instructions and manufacturer information for NorthStar Rx LLC, with manufacturing by Aspiro Pharma Limited, India. The NDC number is 16714-248-01.*

FDA Label Image

Fosaprepitantinjstructure (Fosaprepitantinjstructure)

Chemical structure of Fosaprepitant dimeglumine depicted as a molecular formula diagram showing its specific atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.